# EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

> **NCT00339118** · PHASE4 · UNKNOWN · sponsor: **Sheba Medical Center**

## Conditions studied

- Rhabdomyosarcoma

## Interventions

- **DRUG:** doxorubicin, cytoxan

## Key facts

- **NCT ID:** NCT00339118
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00339118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00339118, "EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00339118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*